Genenta Science
GNTA
5 hedge funds and large institutions have $1.48M invested in Genenta Science in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
41% more capital invested
Capital invested by funds: $1.04M → $1.48M (+$431K)
0.06% more ownership
Funds ownership: 1.87% → 1.93% (+0.06%)
0% more funds holding
Funds holding: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
A
Allianz
Munich,
Germany
|
+$40.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.89K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
1
AlTi Global
New York
| $855K | – | – | – |
|
|
A
2
Allianz
Munich,
Germany
| $441K | +$40.3K | +10,050 | +11% |
|
|
AU
3
Algebris (UK)
London,
United Kingdom
| $170K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $7.95K | +$3.89K | +969 | +109% |
|
5
Morgan Stanley
New York
| $2.13K | – | – | – |
|
GNTA Hedge Fund Activity: Q3 2024 in Review
5 of the 6,967 institutional investors tracked by Wall St. Rank reported a position in Genenta Science (GNTA) for Q3 2024, worth a combined $1.48M — up 41% from $1.04M a quarter earlier.
Fund positioning in GNTA was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Allianz, adding an estimated $40.3K.
- 5 institutional investors held Genenta Science (GNTA) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $1.48M of Genenta Science stock for Q3 2024, up 41% quarter-over-quarter.
- 0 funds opened new Genenta Science positions in Q3 2024 and 0 closed out.
- The largest Genenta Science buyer in Q3 2024 was Allianz, an estimated $40.3K added.
Based on aggregated 13F filings for Q3 2024.